Loading clinical trials...
Loading clinical trials...
With the introducing of neoadjuvant therapy, it becomes ever more important to evaluate the preoperative TNM (cTNM) stage accurately facilitating preoperative treatment as well as the adjuvant therapy...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University
Collaborators
NCT07471841 · IDH1 Mutation, Relapsed / Refractory AML
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT07585006 · Tobacco-Related Carcinoma, Addiction
NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
NCT06274047 · Androgen Axis Suppression, Prostatectomy, and more
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality
301 Hospital
Beijing, Beijing Municipality
302 Military Hospital of China
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions